Home
>
National Drug Code (NDC)
>
Zolpidem Tartrate
Zolpidem Tartrate - 0955-1702-10 - (zolpidem tartrate)
Drug Information of Zolpidem Tartrate
| Product NDC: | 0955-1702 |
| Proprietary Name: | Zolpidem Tartrate |
| Non Proprietary Name: | zolpidem tartrate |
| Active Ingredient(s): | 6.25 mg/1 & nbsp; zolpidem tartrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zolpidem Tartrate
| Product NDC: | 0955-1702 |
| Labeler Name: | Winthrop U.S, a business of sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021774 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20101014 |
Package Information of Zolpidem Tartrate
| Package NDC: | 0955-1702-10 |
| Package Description: | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0955-1702-10) |
NDC Information of Zolpidem Tartrate
| NDC Code | 0955-1702-10 |
| Proprietary Name | Zolpidem Tartrate |
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0955-1702-10) |
| Product NDC | 0955-1702 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zolpidem tartrate |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20101014 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Winthrop U.S, a business of sanofi-aventis U.S. LLC |
| Substance Name | ZOLPIDEM TARTRATE |
| Strength Number | 6.25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [Chemical/Ingredient],Central Nervous System Depression [PE] |
